VYTRUS BIOTECH EO -01 (F:V5P) — Stock Price
VYTRUS BIOTECH EO -01 (F:V5P) is currently trading at €17.10 EUR, up 0.00% today. Over the past 52 weeks, shares have ranged between €4.82 and €21.60. This page tracks VYTRUS BIOTECH EO -01's live share price on the F exchange, its daily price and volume history, and — where reported — its income statement, balance sheet, cash flow statement, and earnings history. For company valuation and market capitalisation context, see V5P company net worth.
VYTRUS BIOTECH EO -01 (V5P) Stock Price Chart — Daily History & Trading Volume
The chart below tracks VYTRUS BIOTECH EO -01's daily closing share price and trading volume on the F exchange over the past year, giving a clear view of recent price momentum and liquidity.
VYTRUS BIOTECH EO -01 Income Statement — Revenue, Profit & Earnings by Year
VYTRUS BIOTECH EO -01's annual income statement shows how revenue converts into profit each fiscal year, including gross profit, operating income, EBITDA, and net income.
| Fiscal Year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total Revenue | €8.37 Million | €5.04 Million | €3.74 Million | €3.68 Million | €2.80 Million |
| Cost of Revenue | €-457.32K | €-453.46K | €-611.01K | €-448.27K | €-449.64K |
| Gross Profit | €8.83 Million | €5.50 Million | €4.35 Million | €4.13 Million | €3.25 Million |
| Research & Development | — | — | — | — | — |
| SG&A | — | — | — | €1.10 Million | €872.81K |
| Total Operating Expenses | €5.19 Million | €4.04 Million | €3.28 Million | €3.04 Million | €2.37 Million |
| Operating Income | €3.18 Million | €1.00 Million | €454.27K | €644.70K | €429.93K |
| EBITDA | — | — | — | — | — |
| EBIT | — | — | — | — | — |
| Interest Expense | — | — | — | — | — |
| Income Before Tax | €3.13 Million | €901.74K | €308.32K | €452.79K | €309.17K |
| Income Tax Expense | — | — | — | — | — |
| Net Income | €2.90 Million | €1.02 Million | €544.94K | €605.26K | €450.02K |
VYTRUS BIOTECH EO -01 Balance Sheet — Assets, Liabilities & Shareholder Equity
The balance sheet below summarizes VYTRUS BIOTECH EO -01's financial position at each fiscal year-end — what it owns (assets), what it owes (liabilities), and the resulting shareholder equity.
| Fiscal Year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total Assets | €14.66 Million | €11.13 Million | €9.31 Million | €8.00 Million | €7.18 Million |
| Total Current Assets | €5.39 Million | €3.79 Million | €2.45 Million | €1.68 Million | €1.82 Million |
| Cash & Equivalents | — | — | — | — | — |
| Short-term Investments | €600.00 | €600.00 | €600.00 | — | €522.14 |
| Net Receivables | €982.01K | €617.79K | €550.26K | €436.31K | €211.12K |
| Inventory | €623.02K | €519.29K | €551.01K | €411.32K | €260.38K |
| Property, Plant & Equipment | — | — | — | — | — |
| Goodwill | — | — | — | — | — |
| Total Liabilities | €4.35 Million | €3.84 Million | €4.02 Million | €3.25 Million | €2.93 Million |
| Total Current Liabilities | €1.78 Million | €1.25 Million | €995.83K | €1.27 Million | €806.12K |
| Long-term Debt | €1.54 Million | €1.99 Million | €2.37 Million | €1.29 Million | €1.54 Million |
| Net Debt | — | — | €1.75 Million | €1.30 Million | €603.20K |
| Total Stockholder Equity | €10.31 Million | €7.29 Million | €5.29 Million | €4.75 Million | €4.25 Million |
| Retained Earnings | €2.90 Million | €1.02 Million | €544.94K | €605.26K | €450.02K |
VYTRUS BIOTECH EO -01 Cash Flow Statement — Operating, Investing & Financing Activities
This cash flow statement breaks down how VYTRUS BIOTECH EO -01 generates and spends cash across operating, investing, and financing activities each fiscal year, including free cash flow and capital expenditures.
| Fiscal Year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating Cash Flow | €3.90 Million | €1.84 Million | €904.39K | €1.03 Million | €447.92K |
| Capital Expenditures | €2.68 Million | €1.20 Million | €1.17 Million | €1.29 Million | €271.82K |
| Free Cash Flow | €1.22 Million | €640.24K | €-261.83K | €-268.62K | €176.11K |
| Investing Cash Flow | — | — | — | — | — |
| Financing Cash Flow | — | — | — | — | — |
| Dividends Paid | — | — | — | — | — |
| Stock-Based Compensation | — | — | — | — | — |
| Depreciation | €974.43K | €829.65K | €725.04K | €691.81K | €576.59K |
| Change in Cash | €847.93K | €1.42 Million | €380.12K | €-558.63K | €190.17K |
VYTRUS BIOTECH EO -01 Earnings History — EPS Actual vs. Analyst Estimates
Track VYTRUS BIOTECH EO -01's quarterly earnings per share (EPS) against Wall Street estimates, along with the earnings surprise percentage for each reporting period.
Earnings history is not currently available for VYTRUS BIOTECH EO -01.